WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011015984) ORALLY ADMINISTERABLE PHARMACEUTICAL PREPARATION CONTAINING INSULIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/015984    International Application No.:    PCT/IB2010/053499
Publication Date: 10.02.2011 International Filing Date: 02.08.2010
IPC:
A61K 38/17 (2006.01), A61K 38/28 (2006.01), A61K 31/195 (2006.01), A61P 5/50 (2006.01)
Applicants: CERA-MED KFT. [HU/HU]; Völgy u 41 H-8230 Balatonfüred (HU) (For All Designated States Except US).
Zoltán, Szilvássy Dr. [HU/HU]; (HU) (For US Only).
Barna, Peitl Dr. [HU/HU]; (HU) (For US Only).
József, Németh Dr. [HU/HU]; (HU) (For US Only)
Inventors: Zoltán, Szilvássy Dr.; (HU).
Barna, Peitl Dr.; (HU).
József, Németh Dr.; (HU)
Agent: Zsuzsa, Emri Dr.; Kartács u 36 H-4032 Debrecen (HU)
Priority Data:
P0900482 03.08.2009 HU
Title (EN) ORALLY ADMINISTERABLE PHARMACEUTICAL PREPARATION CONTAINING INSULIN
(FR) PRÉPARATION PHARMACEUTIQUE POUR L'ADMINISTRATION ORALE CONTENANT DE L'INSULINE
Abstract: front page image
(EN)The subject of the invention is an orally administerable pharmaceutical preparation containing a combination of biotechnologically produced human recombinant insulin and/or modified insulin or an analogue and/or derivative thereof, a protease inhibitor and a high molecular weight (natural) protein. The invention relates to a method for the production of the pharmaceutical preparation as well. The subject of the invention also covers the use of the pharmaceutical preparation and a method for the treatment of diabetes in mammals.
(FR)La présente invention concerne une préparation pharmaceutique pour l'administration orale contenant une combinaison d'insuline humaine recombinante produite par la biotechnologie et/ou d'insuline modifiée ou un analogue et/ou dérivé de celle-ci, d'un inhibiteur de protéase et d'une protéine (naturelle) de poids moléculaire élevé. L'invention concerne également un procédé pour la production de la préparation pharmaceutique. L'invention concerne en outre l'utilisation de la préparation pharmaceutique ainsi qu'un procédé pour le traitement du diabète chez des mammifères.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: Hungarian (HU)